QS Investors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $1.97M | Sell |
45,990
-180
| -0.4% | -$7.57K | 0.02% | 357 |
|
|
2021
Q1 | $1.78M | Sell |
46,170
-1,500
| -3% | -$56.8K | 0.02% | 374 |
|
|
2020
Q4 | $1.71M | Buy |
47,670
+1,884
| +4% | +$67.9K | 0.02% | 369 |
|
|
2020
Q3 | $1.75M | Sell |
45,786
-4,977
| -10% | -$192K | 0.02% | 339 |
|
|
2020
Q2 | $1.78M | Sell |
50,763
-4,479
| -8% | -$161K | 0.02% | 534 |
|
|
2020
Q1 | $1.8M | Sell |
55,242
-2,600
| -4% | -$102K | 0.03% | 456 |
|
|
2019
Q4 | $2.62M | Sell |
57,842
-2,161
| -4% | -$90.4K | 0.03% | 497 |
|
|
2019
Q3 | $2.44M | Sell |
60,003
-1,800
| -3% | -$76.3K | 0.03% | 494 |
|
|
2019
Q2 | $2.66M | Buy |
61,803
+6,000
| +11% | +$231K | 0.03% | 487 |
|
|
2019
Q1 | $2.14M | Sell |
55,803
-928
| -2% | -$35.4K | 0.02% | 578 |
|
|
2018
Q4 | $2M | Hold |
56,731
| – | – | 0.03% | 543 |
|
|
2018
Q3 | $2.18M | Sell |
56,731
-3,000
| -5% | -$105K | 0.02% | 598 |
|
|
2018
Q2 | $1.95M | Buy |
59,731
+2,119
| +4% | +$63.9K | 0.02% | 616 |
|
|
2018
Q1 | $1.57M | Hold |
57,612
| – | – | 0.02% | 653 |
|
|
2017
Q4 | $1.43M | Buy |
57,612
+1,280
| +2% | +$35.3K | 0.01% | 707 |
|
|
2017
Q3 | $1.64M | Sell |
56,332
-700
| -1% | -$19.3K | 0.01% | 674 |
|
|
2017
Q2 | $1.58M | Sell |
57,032
-1,216
| -2% | -$32.3K | 0.01% | 649 |
|
|
2017
Q1 | $1.45M | Buy |
58,248
+40,000
| +219% | +$973K | 0.01% | 687 |
|
|
2016
Q4 | $395K | Hold |
18,248
| – | – | ﹤0.01% | 955 |
|
|
2016
Q3 | $434K | Hold |
18,248
| – | – | ﹤0.01% | 917 |
|
|
2016
Q2 | $426K | Sell |
18,248
-876
| -5% | -$19K | ﹤0.01% | 934 |
|
|
2016
Q1 | $360K | Sell |
19,124
-2,714
| -12% | -$47.7K | ﹤0.01% | 964 |
|
|
2015
Q4 | $403K | Buy |
21,838
+113
| +0.5% | +$2.02K | ﹤0.01% | 943 |
|
|
2015
Q3 | $357K | Hold |
21,725
| – | – | ﹤0.01% | 952 |
|
|
2015
Q2 | $385K | Sell |
21,725
-4,742
| -18% | -$84.7K | ﹤0.01% | 938 |
|
|
2015
Q1 | $471K | Buy |
26,467
+1,444
| +6% | +$22.8K | 0.01% | 887 |
|
|
2014
Q4 | $332K | Hold |
25,023
| – | – | ﹤0.01% | 932 |
|
|
2014
Q3 | $296K | Sell |
25,023
-1,818,100
| -99% | -$22.9M | 0.01% | 510 |
|
|
2014
Q2 | $23.5M | Buy |
1,843,123
+533,481
| +41% | +$6.94M | 0.63% | 38 |
|
|
2014
Q1 | $17.7M | Buy |
1,309,642
+1,282,700
| +4,761% | +$16.8M | 0.53% | 50 |
|
|
2013
Q4 | $323K | Buy |
26,942
+7,333
| +37% | +$86.6K | 0.01% | 487 |
|
|
2013
Q3 | $230K | Sell |
19,609
-7,758
| -28% | -$83.9K | 0.01% | 559 |
|
|
2013
Q2 | $259K | Buy |
+27,367
| New | +$232K | 0.01% | 605 |
|
Other funds holding BSX
BG
QS Investors's BSX Position: Q2 2021 in Review
QS Investors reduced its Boston Scientific (BSX) stake by 0.39% in Q2 2021, selling an estimated $7.57K and leaving 45,990 shares worth $1.97M. The position accounts for 0.02% of the portfolio, ranked #357.
QS Investors first reported a position in BSX in Q2 2013 and has held it in 33 quarters since. The position peaked at $23.5M in Q2 2014. 867 funds tracked by Wall St. Rank hold BSX as of Q2 2021.
- QS Investors held 45,990 shares of Boston Scientific worth $1.97M as of Q2 2021.
- QS Investors sold 180 Boston Scientific shares in Q2 2021, an estimated $7.57K.
- Boston Scientific made up 0.02% of QS Investors's portfolio in Q2 2021, its #357 holding.
- QS Investors first reported a position in Boston Scientific in Q2 2013 and has held it in 33 quarters since.
- QS Investors's Boston Scientific position peaked at $23.5M in Q2 2014.
- 867 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2021.
Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.